EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies.

Nick Barkham, Georg Schett, Xenofon Baraliakos, Filip van den Bosch, Atul Deodhar, Lianne S Gensler, Mikkel ?stergaard, Shital Agawane, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Abhijit Shete, Brian Porter. EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies. Rheumatology. 2020 Apr 1; 59(Supplement_2).

2020
https://researcherprofiles.org/profile/117442078

Nick Barkham, Georg Schett, Xenofon Baraliakos, Filip van den Bosch, Atul Deodhar, Lianne S Gensler, Mikkel ?stergaard, Shital Agawane, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Abhijit Shete, Brian Porter